Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Hartmann

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Clinical and Experimental Medicine|October 7, 2023
Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligenceMax Bittrich, Regina Hetterich, Antonio G Solimando, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRIChristian Linz, Roman C Brands, Olivia Kertels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|September 2, 2022
Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|September 2, 2022
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|February 15, 2018
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancers|March 29, 2023
Adjuvant Radiotherapy in Patients with Squamous Cell Carcinoma of the Oral Cavity or Oropharynx and Solitary Ipsilateral Lymph Node Metastasis (pN1)-A Prospective Multicentric Cohort StudyPeer W Kämmerer, Silke Tribius, Lena Cohrs, et al.
Cell Press Blue|May 18, 2026
An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavityBruno F Matuck, Khoa L A Huynh, Diana Pereira, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Clinical and Experimental Medicine|October 7, 2023
Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligenceMax Bittrich, Regina Hetterich, Antonio G Solimando, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRIChristian Linz, Roman C Brands, Olivia Kertels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|September 2, 2022
Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|September 2, 2022
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|February 15, 2018
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancers|March 29, 2023
Adjuvant Radiotherapy in Patients with Squamous Cell Carcinoma of the Oral Cavity or Oropharynx and Solitary Ipsilateral Lymph Node Metastasis (pN1)-A Prospective Multicentric Cohort StudyPeer W Kämmerer, Silke Tribius, Lena Cohrs, et al.
Cell Press Blue|May 18, 2026
An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavityBruno F Matuck, Khoa L A Huynh, Diana Pereira, et al.
Pageof 10